[Use of fibrin glue in pronounced Dupuytren contracture].
In the surgical treatment of Dupuytren's disease a tissue adhesive, Tissucol (Immuno, Heidelberg), has been used rather than vacuum drainage to reduce postoperative haematoma formation. Tissucol has been used in more than 260 severe cases of Dupuytren's disease. The size of postoperative haematoma formation and the degree of necrosis of wound margins have both been significantly reduced. An earlier return to function has been observed.
D004338:Drug Combinations / Q000627:therapeutic use; D004387:Dupuytren Contracture / Q000601:surgery*; D005176:Factor XIII / Q000627:therapeutic use*; D000071938:Fasciotomy; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000627:therapeutic use*; D006227:Hand Deformities, Acquired / Q000601:surgery*; D006406:Hematoma / Q000517:prevention & control; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D012008:Recurrence; D013710:Tendons / Q000601:surgery; D013917:Thrombin / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen; D005176:Factor XIII; D013917:Thrombin
Die Anwendung des Fibrinklebers bei der ausgeprägten Dupuytren'schen Kontraktur.